Performance of the beta-glucan test for the diagnosis of invasive fusariosis and scedosporiosis: a meta-analysis
Medical Mycology · 2023
DOI: 10.1093/mmy/myad061 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Medical Mycology, 2023. Verfasst von Frederic Lamoth und 15 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Service, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. Hauptthemen laut MEDLINE: Fusariosis, beta-Glucans, Invasive Fungal Infections. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The (1→3)-β-D-glucan (BDG) is a component of the fungal cell wall that can be detected in serum and used as an adjunctive tool for the diagnosis of invasive mold infections (IMI) in patients with hematologic cancer or other immunosuppressive conditions. However, its use is limited by modest sensitivity/specificity, inability to differentiate between fungal pathogens, and lack of detection of mucormycosis. Data about BDG performance for other relevant IMI, such as invasive fusariosis (IF) and invasive scedosporiosis/lomentosporiosis (IS) are scarce. The objective of this study was to assess the sensitivity of BDG for the diagnosis of IF and IS through systematic literature review and meta-analysis. Immunosuppressed patients diagnosed with proven or probable IF and IS, with interpretable BDG data were eligible. A total of 73 IF and 27 IS cases were included. The sensitivity of BDG for IF and IS diagnosis was 76.7% and 81.5%, respectively. In comparison, the sensitivity of serum galactomannan for IF was 27%. Importantly, BDG positivity preceded the diagnosis by conventional methods (culture or histopathology) in 73% and 94% of IF and IS cases, respectively. Specificity was not assessed because of lacking data. In conclusion, BDG testing may be useful in patients with suspected IF or IS. Combining BDG and galactomannan testing may also help differentiating between the different types of IMI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infectious Diseases Service, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
- Institute of Microbiology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
- University Hospital, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
- Grupo Oncoclinicas, Brazil.
- Infectious Disease Unit, Internal Medicine Department, Puerta de Hierro-Majadahonda University Hospital, Fundación de Investigación Puerta de Hierro-Segovia de Arana, Universidad Autónoma de Madrid, Madrid, Spain.
- Médecine Intensive et Réanimation, APHP, Hôpital Saint-Louis, Paris Cité University, Paris, France.
ORCID-Profile: Frederic Lamoth, Marcio Nucci, Ana Fernandez-Cruz, Paul E Verweij, Lewis White, Alexandre Alanio
Zitieren
APA
Lamoth, F., Nucci, M., Fernandez-Cruz, A., Azoulay, E., Lanternier, F., Bremerich, J., Einsele, H., Johnson, E., Lehrnbecher, T., Mercier, T., Porto, L., Verweij, P. E., White, L., Maertens, J., Alanio, A., & 9th European Conference on Infections in Leukemia (ECIL-9) (2023). Performance of the beta-glucan test for the diagnosis of invasive fusariosis and scedosporiosis: a meta-analysis. Medical Mycology. https://doi.org/10.1093/mmy/myad061
Vancouver
Lamoth F, Nucci M, Fernandez-Cruz A, Azoulay E, Lanternier F, Bremerich J, et al. Performance of the beta-glucan test for the diagnosis of invasive fusariosis and scedosporiosis: a meta-analysis. Medical Mycology. 2023. doi:10.1093/mmy/myad061
BibTeX
@article{Lamoth2023,
author = {Lamoth, Frederic and Nucci, Marcio and Fernandez-Cruz, Ana and Azoulay, Elie and Lanternier, Fanny and Bremerich, Jens and Einsele, Hermann and Johnson, Elizabeth and Lehrnbecher, Thomas and Mercier, Toine and Porto, Luciana and Verweij, Paul E and White, Lewis and Maertens, Johan and Alanio, Alexandre and 9th European Conference on Infections in Leukemia (ECIL-9), 9th European Conference on Infections in Leukemia (ECIL-9)},
title = {Performance of the beta-glucan test for the diagnosis of invasive fusariosis and scedosporiosis: a meta-analysis},
journal = {Medical Mycology},
year = {2023},
doi = {10.1093/mmy/myad061}
}
EUVIMED